LT3169307T - Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną - Google Patents

Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Info

Publication number
LT3169307T
LT3169307T LTEP15738918.0T LT15738918T LT3169307T LT 3169307 T LT3169307 T LT 3169307T LT 15738918 T LT15738918 T LT 15738918T LT 3169307 T LT3169307 T LT 3169307T
Authority
LT
Lithuania
Prior art keywords
ibuprophene
aqueous composition
composition including
including paracetamol
paracetamol
Prior art date
Application number
LTEP15738918.0T
Other languages
English (en)
Inventor
Thomas Jacobsen
Original Assignee
Hyloris Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyloris Pharmaceuticals SA filed Critical Hyloris Pharmaceuticals SA
Publication of LT3169307T publication Critical patent/LT3169307T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407Infusion of two or more substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/19Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
LTEP15738918.0T 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną LT3169307T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen
PCT/EP2015/066466 WO2016009067A1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen

Publications (1)

Publication Number Publication Date
LT3169307T true LT3169307T (lt) 2020-07-10

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15738918.0T LT3169307T (lt) 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Country Status (26)

Country Link
US (5) US11219609B2 (lt)
EP (2) EP3656377B1 (lt)
JP (2) JP6745798B2 (lt)
CN (2) CN106794163B (lt)
AR (1) AR100365A1 (lt)
AU (1) AU2015289035B2 (lt)
BR (1) BR112017001093B1 (lt)
CA (1) CA2955557C (lt)
CY (1) CY1122899T1 (lt)
DK (1) DK3169307T3 (lt)
EA (1) EA036212B1 (lt)
ES (2) ES2791349T3 (lt)
HR (1) HRP20200704T1 (lt)
HU (1) HUE048881T2 (lt)
IL (1) IL250112B2 (lt)
LT (1) LT3169307T (lt)
MX (1) MX381776B (lt)
MY (1) MY192813A (lt)
NZ (1) NZ728796A (lt)
PL (2) PL3169307T3 (lt)
PT (1) PT3169307T (lt)
RS (1) RS60289B1 (lt)
SG (1) SG11201700421RA (lt)
SI (1) SI3169307T1 (lt)
TN (1) TN2017000011A1 (lt)
WO (2) WO2016008546A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN109843266B (zh) * 2016-08-02 2023-08-11 安巴知识产权有限公司 稳定的布洛芬注射组合物
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) * 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
AU2022264500A1 (en) * 2021-04-28 2023-11-09 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Alkali metal salt combinations of incompatible active pharmaceutical ingredients
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法
KR20260020463A (ko) 2023-06-02 2026-02-11 이울리아 츠에티 이부프로펜을 포함하는 약학 조성물
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
GR1011104B (el) * 2024-12-18 2026-01-16 Ιουλια Τσετη Προγεμισμενη συριγγα υδατικου διαλυματος παρακεταμολης καταλληλη για ενεσιμη χορηγηση

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) * 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
WO2009083759A1 (en) 2008-01-03 2009-07-09 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
KR20110112279A (ko) * 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PL2389923T3 (pl) * 2010-05-19 2013-06-28 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia iniekcyjny preparat paracetamolu
LT2635269T (lt) * 2010-11-04 2019-09-10 Aft Pharmaceuticals Limited Derinio kompozicija
BE1020614A5 (nl) 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN104302176B (zh) * 2012-03-16 2017-03-22 坎伯兰医药品股份有限公司 可注射布洛芬制剂
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
ES2791349T3 (es) 2020-11-04
WO2016008546A1 (en) 2016-01-21
BR112017001093B1 (pt) 2023-01-31
SI3169307T1 (sl) 2020-07-31
HUE048881T2 (hu) 2020-08-28
CN106794163A (zh) 2017-05-31
MX381776B (es) 2025-03-13
CA2955557A1 (en) 2016-01-21
US20250064764A1 (en) 2025-02-27
IL250112B (en) 2022-10-01
PL3656377T3 (pl) 2025-05-26
US11213498B2 (en) 2022-01-04
US11219609B2 (en) 2022-01-11
CN113018258A (zh) 2021-06-25
TN2017000011A1 (en) 2018-07-04
US20190343785A1 (en) 2019-11-14
JP6745798B2 (ja) 2020-08-26
EA036212B1 (ru) 2020-10-14
JP2017522382A (ja) 2017-08-10
EA201790223A1 (ru) 2017-05-31
US20170209398A1 (en) 2017-07-27
EP3169307B1 (en) 2020-02-19
EP3656377C0 (en) 2025-02-12
MY192813A (en) 2022-09-09
AR100365A1 (es) 2016-09-28
AU2015289035A1 (en) 2017-02-23
WO2016009067A1 (en) 2016-01-21
PT3169307T (pt) 2020-05-18
HRP20200704T1 (hr) 2020-07-24
JP6892494B2 (ja) 2021-06-23
RS60289B1 (sr) 2020-07-31
SG11201700421RA (en) 2017-02-27
IL250112B2 (en) 2023-02-01
US20230181502A1 (en) 2023-06-15
CY1122899T1 (el) 2021-05-05
US20220031645A1 (en) 2022-02-03
EP3656377B1 (en) 2025-02-12
US11389416B2 (en) 2022-07-19
CA2955557C (en) 2021-06-22
US12083087B2 (en) 2024-09-10
AU2015289035B2 (en) 2020-03-26
DK3169307T3 (da) 2020-05-11
EP3656377A1 (en) 2020-05-27
IL250112A0 (en) 2017-03-30
CN106794163B (zh) 2021-03-26
EP3169307A1 (en) 2017-05-24
JP2020059740A (ja) 2020-04-16
NZ728796A (en) 2023-05-26
PL3169307T3 (pl) 2020-09-21
MX2017000764A (es) 2017-08-18
ES3013411T3 (en) 2025-04-11
BR112017001093A2 (pt) 2017-11-14

Similar Documents

Publication Publication Date Title
IL304772A (en) Antibodies, uses and methods
NO2023013I1 (no) Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent
DK3587417T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
LT3221306T (lt) Heteroarilo junginiai, kaip irak inhibitoriai ir jų panaudojimas
LT3317284T (lt) Benzoksazepino oksazolidinono junginiai ir jų naudojimo būdai
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
HRP20260361T1 (hr) Supstituirani 4-fenilpiperidini, njihova priprava i uporaba
LT3240895T (lt) Kompozicijos ir būdai, skirti baltymų glikozilinimui
LT3128005T (lt) Sirp-alfa varianto konstruktai, ir jų panaudojimas
LT3265123T (lt) Antikūnai, naudojimas ir būdai
IL250112B (en) Aqueous formulation comprising paracetamol and ibuprofen
FR3023988B3 (fr) .
LT3347006T (lt) Deuterinti etifoksino analogai, jų dariniai ir panaudojimai
FR3023171B1 (fr) Autoinjecteur.
IL259234B (en) Cephem compounds, their production and use
LT3216451T (lt) Oftalmologinė vandeninė kompozicija
LT3337506T (lt) Deriniai ir jų panaudojimas
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
HUE048394T2 (hu) Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása
DK3166473T3 (da) Oftalmoskoper
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
LT3247711T (lt) Naujos scy-078 druskos ir polimorfai
FR3023170B1 (fr) Autoinjecteur.
BR112016025075A2 (pt) formulação agroquímica.